Industry Veteran Gary Long Appointed New President & CEO for REMPREX, Inc.
LISLE, Ill., Aug. 11, 2025 /PRNewswire/ — REMPREX, Inc. is excited to announce Gary Long has been appointed the new President and Chief Executive Officer,... Read more.
Tier One Credit Union Selects Alkami for Digital Banking
Engagement includes both retail and business banking PLANO, Texas, Aug. 11, 2025 /PRNewswire/ — Alkami Technology, Inc. (Nasdaq: ALKT) (“Alkami”),... Read more.
Avantor® Reiterates Shareholder Value Creation Focus
Emmanuel Ligner, Seasoned Leader with Proven Track Record of Value Creation in Life Sciences, to Begin Role as CEO Next Week RADNOR, Pa., Aug. 11, 2025 /PRNewswire/... Read more.
AGEBOX Presents iKids-Growth: Pioneering Safe and Natural Support for Children’s Height Development
RICHMOND, VA., Aug. 11, 2025 /PRNewswire/ — In the field of pediatric development, a significant advancement is taking shape. For years, parents have navigated... Read more.
Prisidio Applauds AARP’s Launch of Member-Exclusive Digital Vault to Combat Fraud and Preserve Legacies
NAPLES, Fla., Aug. 11, 2025 /PRNewswire/ — Prisidio, the secure digital vault company that helps individuals and families Collect, Protect, and Share their... Read more.
Thumzup Media Corporation Announces Pricing of $50 Million Confidentially Marketed Public Offering at $10 per Share
LOS ANGELES, Aug. 11, 2025 /PRNewswire/ — Thumzup Media Corporation (Nasdaq: TZUP) (“Thumzup” or the “Company”), a digital asset accumulator... Read more.
Intas & Accord signs Agreement to acquire Prothya Biosolutions
AHMEDABAD, India, Aug. 11, 2025 /PRNewswire/ — Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, has announced the execution of an agreement to acquire... Read more.
Nordic and CLEAR partner to offer healthcare organizations a seamless, secure way to manage EHR accounts
MADISON, Wis., Aug. 11, 2025 /PRNewswire/ — Nordic®, a global health and technology consulting company, and CLEAR (NYSE: YOU), the secure identity company,... Read more.
Viatris Announces Approval of First Generic Iron Sucrose Injection in the U.S.
Approval is Another Milestone of Viatris’ Ability to Successfully Develop Complex Generic Medicines Approval Granted with Competitive Generic Therapy Eligibility... Read more.
Viatris Announces Approval of First Generic Iron Sucrose Injection in the U.S.
Approval is Another Milestone of Viatris’ Ability to Successfully Develop Complex Generic Medicines Approval Granted with Competitive Generic Therapy Eligibility... Read more.